Rigel Pharma Signs Licensing Agreement With Arvinas And Pfizer For Veppanu
12/5 13:50
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) on Tuesday said it has entered into a global license agreement with Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE) to develop, manufacture and commercialize beast cancer treatment Veppanu....